Outcomes following surgical management of patellar instability in hypermobile patients are favourable compared to non-operative management in non-hypermobile patients: A systematic review and meta-analysis

对于髌骨不稳的高活动度患者,手术治疗的效果优于非高活动度患者的非手术治疗:一项系统评价和荟萃分析

阅读:1

Abstract

PURPOSE: To assess the outcomes of surgical management of patellar instability in hypermobile patients. METHODS: Three online databases (PubMed, MEDLINE and EMBASE) were searched from inception to 27 September 2024, to identify studies investigating the surgical management options for patellar instability in hypermobile patients. Data pertaining to patient demographics, patient management, redislocation rates and Kujala scores were abstracted. Weighted means and meta-analyses were conducted to compare rates of redislocation as well as post-operative Kujala scores. However, data pooling was not performed in cases of high heterogeneity. The quality of included studies was assessed using the MINORS criteria. RESULTS: A total of nine studies and 303 patients were included in this review. The pooled mean post-operative redislocation rate was 9% at a mean follow-up time of 45.4 months. The mean post-operative redislocation rate ranged from 7.3% to 28.5% following medial patellofemoral reconstruction (MPFLR). The mean post-operative Kujala score ranged from 64.3 to 95.3. The post-operative complication rate was 11.7%. CONCLUSION: This systematic review demonstrated that surgical management, particularly MPFLR, of patellar instability in hypermobile patients may result in lower redislocation rates and favourable post-operative outcomes compared to non-operative management in non-hypermobile patients. The current available literature for this patient population is highly heterogeneous, indicating the need for high-quality studies to more accurately assess intrinsic risk factors and surgical techniques. LEVEL OF EVIDENCE: Level IV.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。